Stock market: Dax continues to chase records - and there is no end in sight

After the lethargy of the past few days, this is the Dax before the weekend again climbed to a record high. Thanks to the convincing business figures of German companies, the leading German index rose by 1,34 percent to 15.459,75 points at the end of trading. With that he managed a week plus of almost one and a half percent.

MDax and SDax also set records. The index of medium-sized stocks ultimately recorded an increase of 0,78 percent to 33.263,21 points. The small cap index, which cracked 16.000 points for the first time the day before, rose 0,91 percent to 16.105,82 points.

Since the beginning of the year, the Dax has gained around eleven percent. With a view to the current reporting season, strategists still see room for improvement, which is due to the increasing global economic dynamism. The experts are primarily relying on positive impulses from the US economy. The planned infrastructure investments of a good two trillion US dollars should support a sustainable industrial recovery in the world's largest economy.

Don't be afraid of US rates

At the same time, investors do not need to fear rising US interest rates. The American Federal Reserve has recently always emphasized that the upcoming price increases are not sustainable. Also from the European Central Bank, the stock exchanges are currently not threatened by rising interest rates.

But there are also analysts who see the Dax as susceptible to a correction. It is true that the environment, with a good economic mood and a continued ultra-loose monetary policy by the central banks, seems made for stocks. But after the unprecedented recovery from the roughly one year old corona low, equity securities are already quite expensive, especially in the USA. The risk of setbacks has increased significantly.

On the part of German companies, things will remain quite calm in the new week. Only on Wednesday evening does a Dax company present figures for the first quarter with Deutsche Börse. The pharmaceutical supplier Sartorius also has quarterly results on the agenda for the middle of the week - the MDax company had already raised its sales and profit forecast for the current year in March.